Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K161378
    Manufacturer
    Date Cleared
    2016-11-02

    (168 days)

    Product Code
    Regulation Number
    878.4400
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    joimax® Bipolar Electrosurgical Instruments
    The joimax® bipolar Vaporflex and Legato electrosurgical instruments are used for coagulation of soft tissue during open or minimally invasive surgical procedures when used in conjunction with a compatible radio frequency generator. The joimax® bipolar electrosurgical instruments have not been shown to be effective for tubal coagulation for sterilization procedures and should not be used for these procedures.

    joimax® Monopolar Electrosurgical Instruments
    The joimax® monopolar Legato electrosurgical instruments are used for cutting and/or coagulating soft tissue during open or minimally invasive surgical procedures when used in conjunction with a compatible radio frequency generator.
    The joimax® monopolar electrosurgical instruments have not been shown to be effective for tubal sterilization or tubal coagulation for sterilization procedures and should not be used for these procedures.

    Device Description

    The joimax® Electrosurgical Instruments are comprised of a series of instruments to facilitate the delivery of electrical energy from an RF generator to the patient tissue for use in cutting and/or coagulation of tissue.
    The joimax® Electrosurgical Instruments use Radio Frequency (RF) energy to induce thermal effects on tissue. The radio frequency is generated by high oscillating electrical current received from a commercially available RF generator.
    The joimax® Probes are available in both monopolar and bipolar probe configurations. All joimax® Probes are designed for specific use with joimax® Handpieces. The joimax Handpieces can be used with compatible commercially available surgical generators.

    AI/ML Overview

    The provided text discusses the joimax® Electrosurgical Instruments and their substantial equivalence to predicate devices, focusing on safety and performance. However, it does not explicitly detail a study with specific acceptance criteria and detailed performance metrics as one might expect for an AI/ML device. The document primarily focuses on demonstrating that the electrosurgical instruments meet general safety and performance standards equivalent to existing legally marketed devices.

    Based on the provided text, here's a breakdown of the requested information, noting where specific details are not available for this type of device (e.g., sample sizes for AI/ML models, expert ground truth for image interpretation).


    1. Table of Acceptance Criteria and Reported Device Performance

    The document does not present a formal table of acceptance criteria with corresponding performance results in a quantitative manner for a comparative study against a specific numerical target. Instead, it confirms compliance with various standards and qualitative comparisons to predicate devices. The "acceptance criteria" are implied by adherence to these standards and the demonstration of similar performance to predicates.

    Acceptance Criterion (Implied)Reported Device Performance
    BiocompatibilityThe device was evaluated according to FDA Blue Book Memorandum #G95-1 and ISO 10993-1. Testing included Cytotoxicity, Irritation, Sensitization, and Acute Systemic Toxicity. The joimax® electrosurgical instruments are considered direct tissue contacting for < 24 hours and the tests confirm biological safety.
    Sterilization/Shelf-LifeBipolar instruments: Validated to achieve a sterility assurance level of 10⁻⁶ using ISO 11137-1/-2. Disposable monopolar instruments: Adopted into a validated EO cycle following AAMI TIR 28:2009. Reusable instruments Moist Heat Sterilization: Validated per ISO 17665-1. Packaging: Validated to ensure sterile barrier integrity per ISO 11607-1.
    Electrical SafetyComplies with IEC 60601-1 standard for safety.
    Electromagnetic Compatibility (EMC)Complies with IEC 60601-1-2 standard for EMC.
    Performance (Functional)Dimensional and Physical Properties: Verification performed to demonstrate instruments met specifications and confirmed physical properties. Ex-vivo Testing: Conducted using multiple types of soft animal tissue (kidney, liver, and muscle tissue). Testing included all ranges of relevant parameters (power settings, activation duration, waveforms/frequencies). Effect on tissue was assessed and determined to be highly comparable to the predicate device. The instruments met all specified criteria and did not raise new safety or performance questions. Performance was found to be similar to the predicate device, indicating suitability for intended use (cutting and/or coagulation of soft tissue).
    Substantial EquivalenceThe testing demonstrated that the performance of the joimax® Electrosurgical Instruments is equal to the legally marketed predicate devices, thus establishing substantial equivalence.

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    For the performance testing, the document states: "Ex-vivo testing was conducted using multiple types of soft animal tissue (kidney, liver and muscle tissue)." It does not specify a numerical sample size for the ex-vivo test set, nor does it provide provenance details like country of origin or whether the data was retrospective or prospective. This is typical for device performance testing involving animal tissue, where the focus is on demonstrating functional equivalence under controlled conditions rather than clinical dataset characteristics.


    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This type of information (number and qualifications of experts for ground truth) is usually relevant for AI/ML devices that interpret data (e.g., images). For electrosurgical instruments, "ground truth" related to tissue effect is typically established through direct observation, standardized pathological assessment, or established physical/chemical measurements by qualified technical personnel or pathologists, rather than expert consensus on interpretation. The document does not specify the number or qualifications of experts involved in assessing the ex-vivo tissue effects, but rather that effect was "assessed."


    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Adjudication methods like 2+1 or 3+1 are typically used for establishing ground truth in AI/ML studies where human interpretation of complex data (like medical images) is involved. For performance testing of electrosurgical devices, the assessment of tissue effect is often based on objective measurements or standardized observational criteria, and thus explicit adjudication among multiple reviewers isn't usually described in this context. The document does not mention any adjudication method for the performance test set.


    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    An MRMC comparative effectiveness study is not mentioned as this device is an electrosurgical instrument, not an AI-assisted diagnostic or interpretive system that human readers would use to improve their performance. Therefore, there is no discussion of human reader improvement with or without AI assistance.


    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This question is not applicable. The device is a physical electrosurgical instrument, not an algorithm. Therefore, "standalone" algorithm performance is not a relevant concept here. The performance described is of the physical instrument itself.


    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    For the performance testing, the "ground truth" for the effect on tissue was likely established through direct observation during ex-vivo testing and possibly subsequent pathological assessment, although pathology is not explicitly named. The document states, "Effect on tissue was assessed and determined to be highly comparable to the predicate device." This "assessment" forms the basis of the functional ground truth for the device's intended use.


    8. The sample size for the training set

    This question is not applicable as this is not an AI/ML device. Therefore, there is no "training set" in the context of machine learning.


    9. How the ground truth for the training set was established

    This question is not applicable as this is not an AI/ML device with a training set.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1